Sinner, F.; Pinter, M.; Scheiner, B.; Ettrich, T.J.; Sturm, N.; Gonzalez-Carmona, M.A.; Waidmann, O.; Finkelmeier, F.; Himmelsbach, V.; De Toni, E.N.;
et al. Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience. Cancers 2022, 14, 5966.
https://doi.org/10.3390/cancers14235966
AMA Style
Sinner F, Pinter M, Scheiner B, Ettrich TJ, Sturm N, Gonzalez-Carmona MA, Waidmann O, Finkelmeier F, Himmelsbach V, De Toni EN,
et al. Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience. Cancers. 2022; 14(23):5966.
https://doi.org/10.3390/cancers14235966
Chicago/Turabian Style
Sinner, Friedrich, Matthias Pinter, Bernhard Scheiner, Thomas Jens Ettrich, Niklas Sturm, Maria A. Gonzalez-Carmona, Oliver Waidmann, Fabian Finkelmeier, Vera Himmelsbach, Enrico N. De Toni,
and et al. 2022. "Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience" Cancers 14, no. 23: 5966.
https://doi.org/10.3390/cancers14235966
APA Style
Sinner, F., Pinter, M., Scheiner, B., Ettrich, T. J., Sturm, N., Gonzalez-Carmona, M. A., Waidmann, O., Finkelmeier, F., Himmelsbach, V., De Toni, E. N., Ben Khaled, N., Mohr, R., Fründt, T. W., Kütting, F., Bömmel, F. v., Lieb, S., Krug, S., Bettinger, D., Schultheiß, M.,
... Venerito, M.
(2022). Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience. Cancers, 14(23), 5966.
https://doi.org/10.3390/cancers14235966
